136 related articles for article (PubMed ID: 36921727)
1. Smoking status in acute myeloid leukemia is associated with worse overall survival and independent of prior nonhematopoietic malignancies, cytogenetic abnormalities, and WHO category.
Kumar J; Patel S; Chang A; Mukherjee S; Small C; Gollapudi S; Butzmann A; Jangam D; Weinberg OK; George TI; Zehnder JL; Ohgami RS
Hum Pathol; 2023 May; 135():45-53. PubMed ID: 36921727
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions.
Bi X; French Z; Palmisiano N; Wen KY; Wilde L
Ann Hematol; 2022 Jun; 101(6):1251-1259. PubMed ID: 35288759
[TBL] [Abstract][Full Text] [Related]
3. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).
Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T
Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.
Song X; Peng Y; Wang X; Chen Y; Jin L; Yang T; Qian M; Ni W; Tong X; Lan J
Acta Haematol; 2018; 139(2):115-127. PubMed ID: 29455198
[TBL] [Abstract][Full Text] [Related]
6. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
Kansal R
Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
[TBL] [Abstract][Full Text] [Related]
7. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.
Weinberg OK; Seetharam M; Ren L; Seo K; Ma L; Merker JD; Gotlib J; Zehnder JL; Arber DA
Blood; 2009 Feb; 113(9):1906-8. PubMed ID: 19131546
[TBL] [Abstract][Full Text] [Related]
8. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
9. Influence of cigarette smoking on the presentation and course of acute myeloid leukemia.
Chelghoum Y; Danaïla C; Belhabri A; Charrin C; Le QH; Michallet M; Fiere D; Thomas X
Ann Oncol; 2002 Oct; 13(10):1621-7. PubMed ID: 12377652
[TBL] [Abstract][Full Text] [Related]
10. Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Vasudevan Nampoothiri R; Tang K; Schuh A; Lam W; Maze D; Michelis FV; Chan S; Gupta V; Kim D; Kumar R; Lipton JH; Mattsson J; Minden M; Schimmer A; Sibai H; Viswabandya A; Yee K; Murphy T; Law AD
Eur J Haematol; 2023 Jun; 110(6):618-625. PubMed ID: 36732677
[TBL] [Abstract][Full Text] [Related]
11. Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.
King RL; Bagg A
Methods Mol Biol; 2017; 1633():1-17. PubMed ID: 28735477
[TBL] [Abstract][Full Text] [Related]
12. The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.
Eisfeld AK; Mrózek K; Kohlschmidt J; Nicolet D; Orwick S; Walker CJ; Kroll KW; Blachly JS; Carroll AJ; Kolitz JE; Powell BL; Wang ES; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Leukemia; 2017 Oct; 31(10):2211-2218. PubMed ID: 28321123
[TBL] [Abstract][Full Text] [Related]
13. De novo acute myeloid leukemia risk factors: a Texas case-control study.
Strom SS; Oum R; Elhor Gbito KY; Garcia-Manero G; Yamamura Y
Cancer; 2012 Sep; 118(18):4589-96. PubMed ID: 22297571
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.
Rosli AA; Azlan A; Rajasegaran Y; Mot YY; Heidenreich O; Yusoff NM; Moses EJ
Clin Exp Med; 2023 Aug; 23(4):1137-1159. PubMed ID: 36229751
[TBL] [Abstract][Full Text] [Related]
16. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.
Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T
Blood; 2003 Oct; 102(7):2395-402. PubMed ID: 12805060
[TBL] [Abstract][Full Text] [Related]
17. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcome.
Jiang G; Capo-Chichi JM; Liu A; Atenafu EG; Guo R; Tierens A; Minden MD; Chang H
Hum Pathol; 2020 Oct; 104():117-126. PubMed ID: 32798550
[TBL] [Abstract][Full Text] [Related]
19. De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.
Akhter A; Patel JL; Farooq F; Qureshi A; Taher-Rad MS; Elyamany G; Al-Zahrani AM; Rashid-Kolvear F; Mansoor A
Appl Immunohistochem Mol Morphol; 2015; 23(10):733-9. PubMed ID: 25710580
[TBL] [Abstract][Full Text] [Related]
20. Smoking adversely affects survival in acute myeloid leukemia patients.
Varadarajan R; Licht AS; Hyland AJ; Ford LA; Sait SN; Block AW; Barcos M; Baer MR; Wang ES; Wetzler M
Int J Cancer; 2012 Mar; 130(6):1451-8. PubMed ID: 21520043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]